AlphaCrest Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $476K | Sell |
|
|||||
|
2022
Q2 | $318K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $570K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $525K | Hold |
|
|||||
|
2021
Q1 | $495K | Sell |
|
|||||
|
2020
Q4 | $680K | Buy |
|
|||||
|
2020
Q3 | $279K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $228K | Buy |
|
|||||
|
2019
Q1 | $188K | Buy |
|